About Essenlix
Essenlix is a company based in Monmouth Junction (United States) founded in 2013. It operates as a HealthTech and Direct-to-Consumer (D2C). Essenlix has raised $20 million across 1 funding round from investors including Carret Private and Quadrant. Essenlix offers products and services including iMOST-L, Q-Card, and iMOST Dock. Essenlix operates in a competitive market with competitors including Withings, Ultrahuman, Oura, iHealth Labs and Masimo, among others.
- Headquarter Monmouth Junction, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Essenlix Corporation
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$20 M (USD)
in 1 rounds
-
Latest Funding Round
$20 M (USD), Series A
Aug 09, 2018
-
Investors
Carret Private
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Essenlix
Essenlix offers a comprehensive portfolio of products and services, including iMOST-L, Q-Card, and iMOST Dock.
Automated device for HGB, WBC, and 5-DIFF analysis.
Single-use biochip with reagents for iMOST analyzer.
Supportive dock for iMOST platform testing operations.
People of Essenlix
Unlock access to complete
Unlock access to complete
Funding Insights of Essenlix
Essenlix has successfully raised a total of $20M through 1 strategic funding round. The most recent funding activity was a Series A round of $20 million completed in August 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Essenlix
Essenlix has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Carret Private and Quadrant.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Quadrant Management is engaged in private equity investments.
|
Locked | Locked | Locked | |
|
Multi-family office services are provided to high net worth families.
|
Locked | Locked | Locked |
Investor details for Essenlix
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Essenlix
Investment portfolio details for Essenlix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Essenlix
Detailed financials for Essenlix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Essenlix Comparisons
Peer comparison for Essenlix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Essenlix
Essenlix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Withings, Ultrahuman, Oura, iHealth Labs and Masimo, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Connected devices for health, sleep, and activity monitoring are developed.
|
|
| Locked | Locked | Locked |
Metabolic health is tracked via devices and fitness platforms.
|
|
| Locked | Locked | Locked |
Health-tracking smart rings and biosensors are developed for biometric monitoring.
|
|
| Locked | Locked | Locked |
Personal healthcare devices for vital monitoring are designed and produced.
|
|
| Locked | Locked | Locked |
Provider of wide range of devices to monitor health parameters
|
|
| Locked | Locked | Locked |
Wearable devices for metabolic health insights are provided.
|
Detailed competitors of Essenlix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Essenlix
Complete news archive for Essenlix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Essenlix
Essenlix was founded in 2013 and raised its 1st funding round 5 years after it was founded.
Essenlix is headquartered in Monmouth Junction, United States. It is registered at Monmouth Junction, New Jersey, United States.
Essenlix is a funded company, having raised a total of $20M across 1 funding round to date.
Essenlix is engaged in transforming health diagnostics through its innovative iMOST platform. The company operates in the healthcare sector, specializing in medical devices for personal and clinical use. Solutions are developed using nanotechnology, advanced imaging, and artificial intelligence to enable instant mobile self-testing. Tests for various biomarkers in body fluids like blood and saliva are provided, delivering lab-quality results quickly. The platform is designed to be user-friendly, cost-effective, and accessible, supporting digital health monitoring worldwide.
Essenlix's top competitors include Withings, Ultrahuman and Oura.
Essenlix offers iMOST-L, Q-Card, and iMOST Dock.
Essenlix has 2 investors. Key investors include Carret Private, and Quadrant.